3 employees
BioEclosion aims to contribute in the development of the next generation of rapid diagnostic test (RDTs) to solve societal challenges.
2016
BioEclosion SL raised undisclosed on May 17, 2021
Investors: MassChallenge Switzerland
BioEclosion SL raised undisclosed on June 20, 2017
Investors: IQS Tech Factory